MARX Biotech Co., Ltd. (7731.TWO)

TWD 7.22

(3.14%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020
Revenue 289.92 Million 110.64 Million 97.6 Million -
Cost of Revenue 75.33 Million 26.43 Million 22.81 Million -
Gross Profit 214.59 Million 84.21 Million 74.79 Million -
Operating Expenses 214.59 Million 82.31 Million 57.9 Million -
Selling, General and Administrative Expenses 228.33 Million 82.31 Million 57.9 Million -
Research and Development Expenses 597 Thousand - - -
Other Expenses - 4.08 Million 2.63 Million -
Cost and Expenses 304.26 Million 108.75 Million 80.72 Million -
Operating Income -14.33 Million 6.01 Million 19.52 Million -
Interest Expense 372 Thousand 114 Thousand 49 Thousand -
Income Tax Expense -2.57 Million 2.07 Million 3.86 Million -
Earnings before Tax -15.48 Million 4.9 Million 17.64 Million -
Net Income -12.91 Million 2.83 Million 13.77 Million -
Earnings Per Share Basic -0.07 0.02 0.10 -
Earnings Per Share Diluted -0.07 0.02 0.10 -
Weighted Average Shares Outstanding 172.93 Million 172.93 Million 137.78 Million 212.37 Million
Weighted Average Shares Outstanding (Diluted) 174.21 Million 174.21 Million 137.78 Million 212.37 Million
Gross Margin 0.74 0.76 0.77 -
EBIT Margin -0.04 0.07 0.21 -
Profit Margin -0.04 0.03 0.14 -
EBITDA -10.52 Million 6.96 Million 19.01 Million -
Earnings Before Tax Margin -0.05 0.05 0.20 -

Income Statement Charts